Info
Enzalutamide
- Delays time to radiographic progression vs. ADT alone in high- & low-volume dz, regardless of prior docetaxel exposure (JCO 2019;37(32):2974). OS data not yet mature
- Emerging evidence for both metastases directed therapy & prostate directed therapy in this dz state